Trump’s Covid-19 antibody treatment was partly developed using Singaporean blood plasma
- One of the two antibodies used in an experimental treatment for the US President was developed using blood samples from three patients in Singapore
- The city state has been recruiting patients who have recovered from the coronavirus to donate blood
The science and technology publication noted that Trump had on Friday received a “high dose” of an experimental antibody therapy known as REGN-COV2 developed by American biotechnology company Regeneron.
What is antibody treatment and how can it help in coronavirus fight?
Trump received the antibody cocktail before he was admitted to the Walter Reed National Military Medical Center, and while he was there for three days, he was also given multiple doses of the antiviral drug, Remdesivir and a steroid dexamethasone, usually used to treat inflammation in people who have severe cases of Covid-19.
Trump was discharged from hospital on Monday evening and in a video released shortly after he was ensconced in the White House said he was feeling better.
Dr Jonathan Reiner, a professor of medicine at George Washington University, told CNN:
“The president might be the only patient on the planet ever to receive this particular combination of medicines.”